Public comments and five listening sessions helped shape the federal 2026-2035 dementia strategy. Rural families can turn that strategy into practical questions about testing, referrals, safety planning, follow-up and caregiver support.
The National Plan to Address Alzheimer's Disease and Related Dementias is the federal strategy for dementia prevention, detection, care and caregiver support. Congress extended the authorizing law through 2035 in the NAPA Reauthorization Act signed Oct. 1, 2024, and required HHS to refresh the plan.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How public input shaped the plan
- What changed in the 2026 update
- Why rural diagnosis often comes later
- What questions bring clearer answers?
- What care and caregiver help to request
How public input shaped the plan
HHS asked for public ideas to guide federal work through 2035 through Request for Information docket HHS-ASPE-2026-0298, with comments due Aug. 15, 2026, according to HHS ASPE in the updated RFI announcement. The request sought input on risk reduction, diagnosis, care and caregiver needs.
HHS also held five public listening sessions with about 250 people living with dementia, caregivers, providers, researchers and tribal and state officials. Those sessions informed the 2026 update. They gave rural voices a direct place in the federal record.
What changed in the 2026 update
HHS released the 2026 Update on Oct. 22, 2026, replacing six historic goals with four lifespan goals, according to HHS in the national plan announcement. The shift moves more attention to prevention and earlier action across life.
The four goals are dementia risk reduction, faster discovery and biomarkers and treatments, high-value care from diagnosis through transitions, and stronger caregiver and family supports. Each goal affects what clinics should offer. Risk reduction points to blood pressure, hearing, activity and vascular care. Discovery points to blood tests and better referrals.
Why rural diagnosis often comes later
Rural Americans face higher dementia risk from an older population. Specialist shortages, long travel, limited PET and biomarker access, and late diagnosis raise costs and caregiver burden. The Information Technology and Innovation Foundation reports that blood-based biomarkers and digital cognitive screens can expand early detection when given by nonspecialists. Primary care and telehealth can carry more of the work.
Workforce rules and payment policies must still change to allow it. Broadband gaps and limited follow-up remain real limits. A brief screen does not equal a full workup. Families need a clear path from screen to answer.
What questions bring clearer answers?
Ask for a baseline test and yearly follow-up. Ask what reversible causes were checked. Ask what biomarker test or specialist referral fits your case.
Bring this short list to the visit: Brief testing is becoming more routine in primary care. The Alzheimer's Association launched the Brain Health and Quality Care Initiative on Oct. 6, 2026 to make brief assessment and follow-up standard. A written result, next step and return date matter more than a score alone.
- Do you do a baseline and annual brief cognitive test?
- Did you check medicines, sleep, mood, thyroid, B12 and other reversible causes?
- Is a blood biomarker, brain scan or specialist referral right for us?
- Can we leave with a written care, safety and driving plan?
- Can follow-up happen by telehealth or with primary care?
What care and caregiver help to request
Ask for a named contact, 24/7 access rules and a transition plan for ER visits, hospital stays and moves. Ask for home safety steps, driving review and a list of local services. Get instructions in writing for the whole family. Medicare's GUIDE Model, launched July 1, 2024 for eight years, pays participating teams for care navigation, 24/7 access, caregiver training and up to $2,500 yearly respite per eligible patient, according to CMS in the GUIDE Model overview.
Ask whether your clinic takes part. If not, ask for the closest respite, adult day, support group or tribal or state program. The plan is strategy, not a cure. Travel, cost and broadband may still slow referrals.
You Might Also Like
- Day-One Subcutaneous Leqembi for Early Alzheimer’s in 2026: Access, Coverage, and Training Questions for Adult Children
- Serious Illness and End-of-Life Dementia Research Priorities in 2026: Cost and Access Questions for Adult Children
- Privacy and Data Access Gaps in 2026 Dementia Research: How Adults With Memory Concerns Can Avoid Overreading the Headline
